IMV INC (IMV)

CA44974L3011 - Common Stock

0.8225  -0.02 (-2.55%)

After market: 0.8 -0.02 (-2.74%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

IMV INC

NASDAQ:IMV (4/28/2023, 7:22:14 PM)

After market: 0.8 -0.02 (-2.74%)

0.8225

-0.02 (-2.55%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap9.63M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

IMV Daily chart

Company Profile

IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. The company is headquartered in Dartmouth, Nova Scotia and currently employs 63 full-time employees. The company went IPO on 2007-10-24. The firm is focused on developing a portfolio of therapies based on DPX, an immune-educating technology platform, that is designed to inform a specific anti-tumor immune response, offering benefit to patients with solid or hematological cancers. Its lead candidate, maveropepimut-S (MVP-S) is a DPX-based immunotherapy that targets survivin-expressing cells for elimination by educated, cytotoxic T cells. Its other candidates include DPX-RSV and DPX-COVID-19. DPX-RSV is a DPX-based vaccine candidate targeting the respiratory syncytial virus (RSV) strain A. The company is focused on developing DPX-COVID-19, a vaccine candidate against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using its DPX platform. The firm is also developing maveropepimut-S for the treatment of breast and ovarian cancer, as well as for Diffuse large B-cell lymphoma (DLBCL) and other malignancies.

Company Info

IMV INC

130 Eileen Stubbs Ave Suite 19

Dartmouth NOVA SCOTIA B3B 2C4

P: 19024921819.0

CEO: Frederic Ors

Employees: 63

Website: https://imv-inc.com/

IMV News

News Imagea year ago - IMV Inc.IMV Receives NASDAQ Delisting Notice
News Imagea year ago - Horizon Technology Finance CorporationHorizon Technology Finance Announces First Quarter 2023 Financial Results

/PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("HRZN", "Horizon" or the "Company"), a leading specialty finance company that provides...

News Imagea year ago - Seeking AlphaIMV stock cut to Neutral at H.C. Wainwright (NASDAQ:IMV)

H.C. Wainwright downgraded immuno-oncology company IMV Inc. to Neutral on Tuesday citing need for more clarity over its ongoing strategic review. Read more here.

News Imagea year ago - IMV Inc.IMV Initiates Restructuring Proceedings Under the CCAA to Complete the Review of its Strategic Alternatives
News Imagea year ago - IMV Inc.IMV Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
News Imagea year ago - IMV Inc.IMV Inc. Announces Changes to Its Board of Directors

IMV Twits

Here you can normally see the latest stock twits on IMV, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example